CN Patent

CN106536538A — 用于治疗黄病毒家族病毒和癌症的2’‑双取代核苷类似物

Assigned to Eutectic Pharmacy Stock Co Ltd · Expires 2017-03-22 · 9y expired

What this patent protects

本发明涉及用于治疗或预防人类受试者或其他动物宿主中的黄病毒科病毒(包括HCV、黄热病、登革热、基孔肯雅和西尼罗病毒)、RSV和流感感染和癌症的化合物、组合物和方法。所述化合物也是其药学上可接受的盐、前药和其它衍生物，作为用于治疗或预防HCV感染的药物组合物和方法。

USPTO Abstract

本发明涉及用于治疗或预防人类受试者或其他动物宿主中的黄病毒科病毒(包括HCV、黄热病、登革热、基孔肯雅和西尼罗病毒)、RSV和流感感染和癌症的化合物、组合物和方法。所述化合物也是其药学上可接受的盐、前药和其它衍生物，作为用于治疗或预防HCV感染的药物组合物和方法。

Drugs covered by this patent

Patent Metadata

Patent number: CN106536538A
Jurisdiction: CN
Classification: —
Expires: 2017-03-22
Drug substance claim: No
Drug product claim: No
Assignee: Eutectic Pharmacy Stock Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.